A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group - Targan, S R; Hanauer, S B; van Deventer, S J (The New England journal of medicine, 1997)
et al.